Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel GLP-1 agonist TTP-273 reduces glucose levels in type 2 diabetes patients

July 7, 2014

PKC, a potential target for NAFLD-related hepatic insulin resistance in type 2 diabetes

July 4, 2014

DGAT1 inhibitor protects beta-cell function under nutrient overload

July 4, 2014

Renal benefits reported for VPI-2690B in a model of diabetic nephropathy

July 4, 2014

Novel radiotracer shows potential for PET imaging of LPA-1 receptor expression

July 4, 2014

Oncoceutics presents preclinical data on lead compound

July 3, 2014

FOXO1 as a potential therapeutic target for diabetes demonstrated with AS-1842856

July 3, 2014

Osteogenesis improved in patients with hypophosphatasia

July 3, 2014

Pharmacodynamic effects of AZD-3241 revealed in PD patients

July 3, 2014

ISIS-GCGRRx improves glycemic control in type 2 diabetes trial

July 2, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026